Edwards Lifesciences Corp

Tredje AP-fonden EW

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/12/2026

Shares

175,573

Value ($000)

14,060

Weight

0.1%

2019 Q4 - 2026 Q1 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/12/2026	14,060	0.1%	175,573	3/31/2026
2024 Q3	11/8/2024	4,025	0.0%	61,000	9/30/2024
2024 Q2	8/12/2024	17,934	0.2%	194,156	6/30/2024
2024 Q1	5/13/2024	20,656	0.2%	216,156	3/31/2024
2023 Q4	2/12/2024	12,898	0.2%	169,156	12/31/2023
2023 Q3	11/9/2023	10,022	0.1%	144,656	9/30/2023
2023 Q2	8/11/2023	14,403	0.2%	152,685	6/30/2023
2023 Q1	5/10/2023	16,009	0.2%	193,505	3/31/2023
2022 Q4	2/10/2023	11,362	0.2%	152,289	12/31/2022
2022 Q3	11/10/2022	5,115	0.1%	61,906	9/30/2022
2022 Q2	8/11/2022	10,901	0.3%	114,639	6/30/2022
2022 Q1	5/9/2022	13,495	0.3%	114,639	3/31/2022
2021 Q4	2/10/2022	11,690	0.2%	90,239	12/31/2021
2021 Q3	11/10/2021	9,283	0.2%	82,000	9/30/2021
2021 Q2	8/6/2021	2,745	0.1%	26,500	6/30/2021
2021 Q1	5/10/2021	2,216	0.1%	26,500	3/31/2021
2020 Q4	2/12/2021	2,418	0.1%	26,500	12/31/2020
2020 Q3	11/10/2020	15,099	0.5%	189,162	9/30/2020
2020 Q2	8/11/2020	13,073	0.5%	189,162	6/30/2020
2020 Q1	5/28/2020	11,893	0.6%	63,054	3/31/2020
2019 Q4	2/10/2020	4,056	0.2%	17,388	12/31/2019